Jayagopal Ashwath 4
4 · Ocuphire Pharma, Inc. · Filed May 24, 2024
Insider Transaction Report
Form 4
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Transactions
- Purchase
Common Stock
2024-05-22$1.76/sh+3,500$6,178→ 78,500 total
4 · Ocuphire Pharma, Inc. · Filed May 24, 2024
Common Stock